Center on Health Equity & Access
Clinical
Health Care Cost
Health Care Delivery
Insurance
Policy
Technology
Value-Based Care

Biosimilars Cardiorenalmetabolic Dermatology Gastroenterology Hematology Hepatology Immunology Infectious Disease Mental Health Neurology Obesity Oncology Ophthalmology Pulmonology Rare Disease Respiratory Rheumatology Women's Health

Free In-Person Regional Events Focused on Oncology and Population Health

Biosimilars Center on Health Equity & Access Digital Health Formulary Gene Therapy Guidelines Health Care Administration Health Care Cost Health Care Delivery Insurance Policy Population Health Product Approvals and Launches Technology Value-Based Care

All Coverage Event Coverage Interviews News

AJMC Journals Anniversary Author Forms Authors Nominate a Rising Leader Submit a Manuscript

Ivo Carre, PhD

home / authors / ivo-carre-phd

Ivo Carre, PhD, is a senior business analyst at Lifescience Dynamics.

Articles

Ivo Carre, PhD

Emerging Data Suggest Select Benefit for Venetoclax in MDS: Ivo Carre, PhD

December 7th 2025

Ivo Carre, PhD, shares subgroup data that points to potential benefit in younger patients with high-risk MDS.

Ivo Carre, PhD, senior business analyst, Lifescience Dynamics

Targeted Therapies, Key Subgroup Insights to Watch at ASH 2025

December 5th 2025

New data in high-risk MDS, emerging menin inhibitors in AML, and evolving care needs in rare bleeding disorders set the stage for major ASH 2025 discussions.

Editorial Boards

Do Not Sell My Information

Terms & Conditions

Contact Info

2 Commerce Drive
Cranbury, NJ 08512

© 2025 MJH Life Sciences
AJMC®
All rights reserved.